Cite
HARVARD Citation
Dufner, V. et al. (2021). P04.17 Antigen heterogeneity in glioblastoma cell lines, patient-derived cells, and patients' glioblastoma tissue is an obstacle for CAR-T cell therapy development. Neuro-oncology. pp. ii21-ii22. [Online].